Acumen Pharmaceuticals Inc Return on Total Capital (ROTC) 5 year CAGR is NA for the Trailing 12 Months (TTM) ending March 31, 2024. Return on total capital measures the profitability of a company relative to its total capital, which includes total debt and shareholders' equity. It is calculated by dividing the net income by the sum of total debt and shareholders' equity. This ratio provides insights into the return generated for each unit of total capital invested in the company. A higher return on total capital indicates better profitability and efficient utilization of both debt and equity capital. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.